×
Please click
here
if you are not redirected within a few seconds.
All
News
Videos
Images
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
C4X Discovery (LON:C4XD) Stock Price Passes Below 50-Day Moving Average of $10.80
Defense World
C4X Discovery Holdings plc (LON:C4XD – Get Free Report) shares crossed below its 50-day moving average during trading on Monday .
2 days ago
AIM market takes a hit as C4X looks to delist
BioCentury
The AIM market on the London Stock Exchange took a knock to its reputation on Wednesday after one of the biotechs listed on the exchange...
2 months ago
C4X Discovery Moves to Private Trading
TipRanks
C4X Discovery Holdings (GB:C4XD) has released an update. C4X Discovery Holdings PLC has confirmed the last trading day of its shares on AIM is today,...
1 month ago
C4X Discovery to Delist From AIM Due to Downturn in Financial Markets
MarketWatch
C4X Discovery to Delist From AIM Due to Downturn in Financial Markets ... C4X Discovery Holdings said it intends to delist from London's AIM and...
2 months ago
Redx joins C4X in delisting from AIM due to liquidity issues
Pharmaphorum
Redx Pharma has decided it would be better off in private hands than publicly listed on the UK AIM, and has started the process of exiting...
2 months ago
C4X Discovery Holdings PLC Announces Divestment of Orexin-1 to Indivior for £15.95m
Yahoo Finance
August 1, 2023 / C4X Discovery Holdings plc (AIM:C4XD), a pioneering Drug Discovery company, today announces the execution of an asset...
10 months ago
C4X Discovery shares soar on $11m COPD payment from AstraZeneca
Sharecast.com
C4X Discovery, the AIM-listed drug discovery company, has received a "milestone payment" of $11m from biopharma giant AstraZeneca as part of...
5 months ago
C4X Discovery CEO says delisting decision not taken lightly
Proactive Investors
Use of technology ... C4X Discovery Holdings PLC (AIM:C4XD) CEO Clive Dix said the decision to delist the drug developer had not been taken...
2 months ago
Another listed company plans to quit London's AIM market - this is why
City A.M.
Drug company C4X Discovery has announced plans to quit the London Stock Exchange's AIM next month - this is why.
2 months ago
C4X to quit stock market and seek venture funding for drug discovery | TheBusinessDesk.com
TheBusinessDesk.com
The Manchester-based business floated on AIM in 2014, at 100p a share, hitting a high of 117.5p in July 2016, but at the close of market...
2 months ago